Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Flumazenil/Naltrexone - Trexapharm

Next Previous
X
Search
Drug Profile

Flumazenil/Naltrexone - Trexapharm

Alternative Names: Naltrexone/Flumazenil - Trexapharm

Latest Information Update: 28 May 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Trexapharm
  • Class Antidepressants; Antidotes; Antivirals; Benzodiazepinones; Cyclopropanes; Drug withdrawal therapies; Esters; Ethers; Eye disorder therapies; Fluorine compounds; Imidazoles; Irritable bowel syndrome therapies; Ketones; Morphinans; Non-opioid analgesics; Small molecules
  • Mechanism of Action GABA A receptor antagonists; Opioid receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Major depressive disorder

Most Recent Events

  • 28 May 2024 No recent reports of development identified for clinical-Phase-Unknown development in Major depressive disorder(In the elderly, In adults) in Australia (SC, Infusion)
  • 22 Apr 2021 Clinical trials in Major depressive disorder (In adults, In the elderly) in Australia (SC) (ACTRN12621000310864)
  • 25 Mar 2021 Preclinical trials in Major depressive disorder in Australia (SC) before March 2021

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top